RADA16 for Aquablation Day Case

Starting soon · Phase 2

Conditions studied: Hematuria, Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms

In brief

This is a pilot proof of concept single-arm study using PuraStat following Aquablation procedure to assess reduction of hematuria to allow for same day discharge. The primary objective is to assess how PuraStat affects post-operative hematuria following Aquablation. The secondary objective is to assess the number of patients discharged on the same day based on the hematuria criteria (Grade 0 and Grade I).

Key facts

Study ID

NCT06948331

Run by

NYU Langone Health

People needed

25

Starts

2026-04-01

Expected to finish

2026-08-01

Last updated by the study team

2026-02-27

Who can join

Age: any. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Any man undergoing Aquablation for LUTS due to BPH

You may not qualify if…

• Unwilling to sign consent

Where it is running

• NYU Langone Health — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.